EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Thursday reported a loss of $5.5 million in its first quarter.
On a per-share basis, the Ewing, New Jersey-based company said it had a loss of 3 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 4 cents per share.
The drugmaker posted revenue of $23.3 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $17.5 million.
The company's shares closed at $2.74. A year ago, they were trading at $2.33.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS